All Insights White Paper COVID-19 Recession Effects On Pharmaceutical-Related Patient Health Outcomes
COVID-19 Recession Effects On Pharmaceutical-Related Patient Health Outcomes
Updated in June 2020
![COVID-19 Recession Effects On Pharmaceutical-Related Patient Health Outcomes](https://insights.axtria.com/hubfs/Axtria-2023/media-wall/How-has-COVID-19-Accelerated-the-Need-400x250.jpg)
This white paper investigates the research framework to model the expected effects of the decline in health outcomes caused by a decrease in the quantity and quality of pharmaceutical utilization due to the economic effects of a deep and long recession. Four effects caused by a deep recession that will adversely affect the utilization of branded/biologic drugs, which, in turn, will cause a decrease in patient health outcomes, are reviewed: 1) market access, 2) plan control/design, 3) affordability, and 4) government control (state Medicaid). This paper will close by addressing five actions pharma companies need to take in response to these adverse effects on patient health outcomes: 1) understand managed market effects, 2) predict in real-time future local economic conditions, 3) provide information and assistance that will improve long-term patient adherence, 4) create a robust analytical capability to produce actionable business insights in real-time, and 5) develop an efficient data management structure to support analytical capabilities.
Contact us at insights@axtria.com with any questions.
Complete the brief form to download the white paper
Recommended insights
![Impact of COVID-19 on Patient Health Outcomes in the Pharmaceutical](https://insights.axtria.com/hubfs/Pharmaceutical%20Economic%20Analysis%20of%20COVID-19_featured%20%28comp%29.jpg)
Blog
Continued Need for Pharmaceutical Economic Analysis of COVID-19 Induced Effects on Drug Demand
![Impact of COVID-19 on Patient Health Outcomes in the Pharmaceutical](https://insights.axtria.com/hubfs/How%20Will%20The%20COVID-19%20Induced%20Recession%20Affect%20State%20Medicaid%20Drug%20Utilization.jpg)
White Paper